----

Exhibit 31.1

**CERTIFICATION OF PRINCIPAL    EXECUTIVE OFFICER**** ****AND****PRINCIPAL FINANCIAL OFFICER**** PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Richard Falcone, certify that:

1. I have reviewed this annual report on Form 10-K of Aquamer Medical Corp.;

2. Based on my knowledge, this amended annual report does not contain any    untrue statement of a material fact or omit to state a material fact necessary    to make the statements made, in light of the circumstances under which such statements    were made, not misleading with respect to the period covered by this amended    annual report;

3. Based on my knowledge, the financial statements, and other financial    information included in this annual report, fairly present in all material    respects the financial condition, results of operations and cash flows of the    registrant as of, and for, the periods presented in this annual report;

4. I am responsible for establishing and maintaining disclosure controls and    procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and    internal control over financial reporting (as defined in Exchange Act Rules    13a-15(f) and 15d-15(f)) for the registrant and have:

            (a)    designed such disclosure controls and procedures, or caused such disclosure    controls and procedures to be designed under my supervision, to ensure that    material information relating to the registrant, including its consolidated    subsidiaries, is made known to me by others within those entities, particularly    during the period in which this amended annual report is being prepared;

            (b)    designed such internal control over financial reporting, or caused such    internal control over financial reporting to be designed under my supervision,    to provide reasonable assurance regarding the reliability of financial    reporting and the preparation of financial statements for external purposes in    accordance with generally accepted accounting principles;

            (c)    evaluated the effectiveness of the registrant's disclosure controls and    procedures and presented in this report my conclusions about the effectiveness    of the disclosure controls and procedures, as of the end of the period covered    by this report based on such evaluation; and

            (d)    disclosed in this report any change in the registrant's internal control over    financial reporting that occurred during the registrant's most recent fiscal    quarter (the registrant's fourth fiscal quarter of the annual report) that has    materially affected or is reasonably likely to materially affect, the    registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control    over financial reporting, to the registrant's auditor and the audit committee    of the registrant's board of directors (or persons performing the equivalent    functions):

            (a) all    significant deficiencies and material weaknesses in the design or operation of    internal control over financial reporting which are reasonably likely to    adversely affect the registrant's ability to record, process, summarize and    report financial information; and

            (b) any    fraud, whether or not material, that involves management or other employees who    have a significant role in the registrant's internal control over financial    reporting.

Date: April 15, 2010

| /s/ Richard Falcone                                            |
|----------------------------------------------------------------|
|                                                                |
| Richard Falcone          President and Chief Executive Officer |